Related Experiment Video
Updated: Apr 17, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Extra-cranial giant cell arteritis and Takayasu arteritis: How similar are they?
Tanaz A Kermani1, Cynthia S Crowson2, Francesco Muratore3
1Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, 2020 Santa Monica Boulevard, Suite 540, Los Angeles, CA 90404.
Insights
Giant cell arteritis (GCA) with upper extremity (UE) involvement differs from Takayasu arteritis (TAK) in patient demographics and vascular imaging. Aortic aneurysms are more common in GCA, while stenotic changes prevail in TAK.
Area of Science:
- Vascular Medicine
- Rheumatology
- Internal Medicine
Background:
- Giant cell arteritis (GCA) and Takayasu arteritis (TAK) are large vessel vasculitides.
- Distinguishing between GCA with upper extremity (UE) involvement and TAK is crucial for appropriate management.
- Clinical and imaging features can aid in differentiating these conditions.
Purpose of the Study:
- To compare the clinical and imaging characteristics of patients with GCA and UE arterial involvement to those with TAK.
- To identify key differentiating features between GCA and TAK.
Main Methods:
- Retrospective analysis of patients diagnosed with TAK (1984-2009) and GCA with UE involvement (1999-2008) at the Mayo Clinic.
- Comparison of demographic data, clinical presentation, and imaging findings between the two cohorts.
Main Results:
- The TAK cohort (n=125) had a mean age of 30.9 years, while the GCA cohort (n=120) had a mean age of 67.8 years.
- Time to diagnosis was significantly longer in TAK (3.2 years) than GCA (0.5 years).
- Aortic aneurysms were more frequent in GCA (100%) compared to TAK (19%), whereas stenotic/occlusive lesions were predominant in TAK (81%) versus GCA (0%).
Conclusions:
- GCA with UE involvement and TAK exhibit distinct clinical and imaging profiles.
- Aortic aneurysms are more characteristic of GCA, while stenotic changes are more indicative of TAK.
- These differences suggest potentially divergent pathophysiologic mechanisms or vascular responses to injury.
Objective:
To compare clinical and imaging characteristics of patients with giant cell arteritis (GCA) and upper extremity (UE) arterial involvement to patients with Takayasu arteritis (TAK).
Methods:
A cohort of patients seen at the Mayo Clinic with TAK diagnosed between 1984 and 2009 and a cohort of patients with GCA and UE arterial involvement diagnosed between 1999 and 2008 were studied.
Results:
The TAK cohort consisted of 125 patients (91% female); the mean age (±SD) at diagnosis was 30.9 (±10) years. The cohort of patients with GCA and UE involvement comprised of 120 patients (80% female); the mean age (±SD) at diagnosis was 67.8 (±7.5) years. The mean time from onset of symptoms to diagnosis was significantly longer in TAK (3.2 years) than GCA (0.5 years), p < 0.001. UE claudication was reported in 40% with TAK and 53% with GCA, p = 0.04. UE blood pressure discrepancy was present in 65% with TAK versus 28% with GCA, p < 0.001. Involvement of the thoracic aorta, abdominal aorta, carotid arteries, innominate artery, mesenteric artery, and left renal artery was more frequently observed in TAK (p < 0.05). Among patients with luminal changes of the thoracic aorta, stenotic/occlusive lesions were predominant in TAK (81% compared to 0% in GCA), whereas aneurysmal disease was more common in GCA (100% compared with 19% in TAK, p < 0.001).
Conclusion:
Patients with GCA and UE involvement differ from patients with TAK in clinical and imaging characteristics. Aortic aneurysms were more common in GCA, while stenotic changes of the aorta were more common in TAK, suggesting different pathophysiologic mechanisms or vascular response to injury.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

